Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer

Journal of Urology

Volumn 185, Issue 6, 2011, Pages 2102-2107

  Barocas, Daniel A ^a   Motley, Saundra ^a   Cookson, Michael S ^a   Chang, Sam S ^a   Penson, David F ^a,b   Dai, Qi ^a   Milne, Ginger ^a   Roberts II, L Jackson ^a   Morrow, Jason ^a   Concepcion, Raoul S ^a,c   Smith Jr , Joseph A ^a   Fowke, Jay H ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Urology Associates   (United States)

Author keywords

biopsy; isoprostanes; oxidative stress; prostatic intraepithelial neoplasia; prostatic neoplasms

Indexed keywords

ISOPROSTANE DERIVATIVE; PROSTAGLANDIN F2; PROSTAGLANDIN F2 ISOPROSTANE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; GAS CHROMATOGRAPHY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MORPHOMETRICS; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN URINE LEVEL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

AGED; CASE-CONTROL STUDIES; F2-ISOPROSTANES; HUMANS; MALE; OXIDATIVE STRESS; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 79955840207     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2011.02.020     Document Type: Article

References (30)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225
2. S.K. Pathak, R.A. Sharma, and W.P. Steward Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies Eur J Cancer 41 2005 61
3. A.M. De Marzo, E.A. Platz, and S. Sutcliffe Inflammation in prostate carcinogenesis Nat Rev Cancer 7 2007 256
4. S.J. Freedland, W.J. Aronson, and C.J. Kane Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group J Clin Oncol 22 2004 446
5. W.G. Nelson, A.M. De Marzo, and W.B. Isaacs Prostate cancer N Engl J Med 349 2003 366
6. Z. Gong, M.L. Neuhouser, and P.J. Goodman Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial Cancer Epidemiol Biomarkers Prev 15 2006 1977
7. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group N Engl J Med 330 1994 1029
8. M. Etminan, B. Takkouche, and F. Caamao-Isorna The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies Cancer Epidemiol Biomarkers Prev 13 2004 340
9. L.C. Clark, G.F. Combs Jr, and B.W. Turnbull Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin A randomized controlled trial. Nutritional Prevention of Cancer Study Group JAMA 276 1996 1957
10. M.R. Smith, J. Manola, and D.S. Kaufman Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy J Clin Oncol 24 2006 2723
11. R.J. Hamilton, K.C. Goldberg, and E.A. Platz The influence of statin medications on prostate-specific antigen levels J Natl Cancer Inst 100 2008 1511
12. J.H. Fowke, S.S. Motley, and M. Wills Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia Cancer Causes Control 18 2007 375
13. J.D. Morrow, W.E. Zackert, and J.P. Yang Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay Anal Biochem 269 1999 326
14. J.D. Brooks, M. Weinstein, and X. Lin CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia Cancer Epidemiol Biomarkers Prev 7 1998 531
15. N.N. Tam, I. Leav, and S.M. Ho Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat Am J Pathol 171 2007 1334
16. S.M. Lippman, E.A. Klein, and P.J. Goodman Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) JAMA 301 2009 39
17. J.M. Gaziano, R.J. Glynn, and W.G. Christen Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial JAMA 301 2009 52
18. H.S. Basu, T.A. Thompson, and D.R. Church A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model Cancer Res 69 2009 7689
19. D.G. Bostwick, E.E. Alexander, and R. Singh Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer Cancer 89 2000 123
20. C.C. Chiou, P.Y. Chang, and E.C. Chan Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers Clin Chim Acta 334 2003 87
21. Z. Arsova-Sarafinovska, A. Eken, and N. Matevska Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer Clin Biochem 42 2009 1228
22. O. Yossepowitch, I. Pinchuk, and U. Gur Advanced but not localized prostate cancer is associated with increased oxidative stress J Urol 178 2007 1238
23. J.K. Gill, A.A. Franke, and J. Steven Morris Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort Cancer Causes Control 20 2009 1161
24. Z. Latif, D.C. McMillan, and A.M. Wallace The relationship of circulating insulin-like growth factor 1, its binding protein-3, prostate-specific antigen and C-reactive protein with disease stage in prostate cancer BJU Int 89 2002 396
25. D.C. McMillan, D. Talwar, and N. Sattar The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours Clin Nutr 21 2002 161
26. M.B. Kadiiska, B.C. Gladen, and D.D. Baird Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 38 2005 698
27. D. Il'yasova, J.D. Morrow, and A. Ivanova Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane Ann Epidemiol 14 2004 793
28. D.R. Cottam, S.G. Mattar, and E. Barinas-Mitchell The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss Obes Surg 14 2004 589
29. I.J. Tsai, K.D. Croft, and T.A. Mori 20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction Free Radic Biol Med 46 2009 263
30. S. Basu F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications Antioxid Redox Signal 10 2008 1405